Currentselect_healthPolicy CCP.1326

Customized lymphedema compression garments

Customize your policy alerts

Sign up for select_health Policy CCP.1326 alerts

Get alerted when Policy CCP.1326 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

This policy governs medical necessity and coverage criteria for customized compression garments used to treat lymphedema for Select Health of South Carolina members and describes contraindications, replacement frequency, and related services.

Policy Summary

Payerselect_health

PolicyCustomized lymphedema compression garments

Policy CodePolicy CCP.1326

Change TypeMinor review — no material coverage changes

Effective DateApr 1, 2025

Last ReviewDec 1, 2025

Next Review DateApr 1, 2027

Key ActionObtain and document a diagnosis of lymphedema, demonstrate minimized and stabilized swelling, and ensure the garment is prescribed by a credentialed lymphedema expert or treating physician for authorization.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

4-6replacement interval (months)

2garments required

<0.6ABI threshold

NYHA IVcardiac contraindication

OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

Currentselect_healthPolicy CCP.1326

Customized lymphedema compression garments

Customize your policy alerts

Sign up for select_health Policy CCP.1326 alerts

Get alerted when Policy CCP.1326 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Policy Summary

Payerselect_health

PolicyCustomized lymphedema compression garments

Policy CodePolicy CCP.1326

Change TypeMinor review — no material coverage changes

Effective DateApr 1, 2025

Last ReviewDec 1, 2025

Next Review DateApr 1, 2027

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

4-6replacement interval (months)

2garments required

<0.6ABI threshold

NYHA IVcardiac contraindication

consensusevidence basis

Coverage & Medical Necessity

Medical necessity criteria

Customized compression garments for lymphedema are covered when ALL of the following are met:

Coverage criteria: Lymphedema has been diagnosed and documented by the treating physician; the condition impairs activities of daily living, limb use, safe transfers, or mobility; any swelling from the lymphedema has been minimized; the affected area has been stabilized; no contraindications to compression exist; and the garment is prescribed by a credentialed lymphedema expert or treating physician.

Based on International Society of Lymphology and NCCN guidance.

Compression garments are contraindicated when specified vascular, cardiac, neurologic, infectious, or material-allergy risks are present. Contraindications include severe peripheral arterial occlusive disease defined by any of the following thresholds: Ankle Brachial Index (ABI) < 0.6, ankle pressure < 60 mmHg, toe pressure < 30 mmHg, or transcutaneous oxygen pressure < 20 mmHg.

Other exclusions include suspected compression of an existing epifascial arterial bypass, severe cardiac insufficiency (NYHA class IV), and routine application in NYHA class III without strict indication and clinical or hemodynamic monitoring. Garments are also contraindicated for patients with a confirmed allergy to compression material or severe diabetic neuropathy with sensory loss or microangiopathy and risk of skin necrosis.

Because compression can worsen underlying arterial or ischemic conditions, garments should be prescribed only after assessment for these contraindications and appropriate vascular or cardiac evaluation when indicated.

Clinical Thresholds & Measurement Limits

inv-03: Ankle Brachial Index (ABI)

Ankle Brachial Index (ABI) threshold< 0.6

Clinical contextABI < 0.6 is listed as a contraindication to compression garment therapy due to severe peripheral arterial occlusive disease.

Source guidanceInternational Society of Lymphology and consensus guidelines note ABI < 0.6 as a primary exclusion criterion.

inv-04: Ankle pressure

Ankle pressure threshold< 60 mmHg

Clinical contextAnkle pressure < 60 mmHg indicates severe peripheral arterial occlusive disease and is a contraindication to compression garments.

Provider Requirements, Authorization & Documentation

Prior Authorization

Prior authorization: medical necessity criteria

Customized compression garments may be authorized when all specified medical necessity criteria are met: lymphedema is diagnosed and documented by the treating physician; the condition impairs activities of daily living, limb use, safe transfers, or mobility; any swelling has been minimized; the affected area has been stabilized; there are no contraindications; and the garment is prescribed by a credentialed lymphedema expert or treating physician. Garments should be replaced every 4–6 months and the member must maintain two of each garment at all times.

Authorization requires documentation of diagnosis, minimized swelling, stabilization, absence of contraindications, and prescription by a credentialed lymphedema expert or treating physician.
Replacement interval: every 4–6 months; member must maintain two of each garment.

Step Therapy

Conservative therapy alternatives

Provide or document prior use of conservative, non-surgical management options — compression bandaging, physical therapy, drug therapy, and psychosocial rehabilitation — as these are listed alternative covered services and part of standard management.

Clinical Background

Lymphedema is a manifestation of lymphatic system insufficiency that causes limb or regional swelling and can progress to tissue changes and impaired function. It may be primary or secondary (for example, secondary to cancer treatment), and is staged clinically from latent (Stage 0) through Stage III (lymphostatic elephantiasis with trophic skin changes). Early intervention can limit progression.

Diagnosis may be supported by imaging such as lymphoscintigraphy. Standard non‑surgical management emphasizes decongestive therapies—manual lymphatic drainage, compression bandaging, and compression garments—to reduce limb volume, preserve skin integrity, and maintain function. Compression garments may be effective when used alone in early (Stage I) or breast cancer–related lymphedema to prevent fluid accumulation and minimize volume change, while evidence for later stages is limited.

When considering custom garments, prescribers should ensure the patient has received appropriate conservative therapy and that swelling has been minimized and the affected area stabilized before custom garments are fitted and provided.

Definitions & Staging

inv-12: Customized compression garment definition

DefinitionA knitted, two-way stretch sleeve or stocking fabricated to apply specific pressure to a body part, custom fitted and prescribed to maintain volume control and skin health.

PurposeWorn to assist in controlling swelling and aid movement of lymphatic fluid from the affected area.

Replacement intervalEffectiveness lasts 4–6 months; replacement recommended at the end of that period.

Fit and prescriptionShould be custom fitted and prescribed according to the patient's ability to manage the garment to maintain best volume control and skin health.

inv-13: Lymphedema staging

Staging systemInternational Society of Lymphology stages 0–III (Stage 0 latent/subclinical to Stage III lymphostatic elephantiasis).

Policy Summary

Payerselect_health

PolicyCustomized lymphedema compression garments

Policy CodePolicy CCP.1326

Change TypeMinor review — no material coverage changes

Effective DateApr 1, 2025

Last ReviewDec 1, 2025

Next Review DateApr 1, 2027

SourceLink

On This Page

Measured ankle pressure below this threshold excludes garment therapy unless managed appropriately.

inv-05: Toe pressure

Toe pressure threshold< 30 mmHg

Clinical contextToe pressure < 30 mmHg is cited as a contraindication to compression garment therapy for peripheral arterial disease.

ImplicationIf toe pressure is below this value, compression should be avoided due to risk of ischemic complications.

inv-06: Transcutaneous oxygen pressure

Transcutaneous oxygen pressure (TcPO2) threshold< 20 mmHg

Clinical contextTcPO2 < 20 mmHg identifies severe peripheral arterial disease and is listed as a contraindication to compression therapy.

Clinical implicationLow TcPO2 suggests poor tissue perfusion; compression garments are contraindicated to avoid worsening ischemia.

Compression bandaging is an effective initial treatment and may be required or considered before custom garments for some patients.
Physical therapy, drug therapy, and psychosocial rehabilitation are alternative covered services.

Documentation Required

Required clinical documentation

Document the treating physician’s diagnosis of lymphedema, evidence that swelling has been minimized and the affected area stabilized, functional impairment (impact on ADLs, limb use, transfers, or mobility), and that the garment was prescribed by a credentialed lymphedema expert or treating physician.

Include objective notes on swelling reduction and stabilization.
Record functional limitations (ADLs, mobility, transfers) attributable to lymphedema.
Ensure prescription is by a credentialed lymphedema expert or the treating physician.

Denial Risk

Documentation-driven denials

Failure to provide required documentation — diagnosis by the treating physician, evidence swelling has been minimized and the area stabilized, absence of contraindications, and prescription by a credentialed lymphedema expert or treating physician — may result in denial of coverage.

Missing documentation of minimized swelling or stabilization is a common cause for denial.
Unaddressed contraindications (e.g., severe peripheral arterial disease, NYHA class IV heart failure, allergy to compression material) may lead to denial.

Stage 0Latent/subclinical condition: impaired lymphatic transport without evident swelling.

Stage IEarly fluid accumulation, often pitting; may respond to elevation and conservative therapy.

Stage IIChanges in solid structures and persistent swelling; limb elevation rarely reduces tissue swelling; later Stage II may develop fibrosis and loss of pitting.

Stage IIILymphostatic elephantiasis with trophic skin changes, fat deposition, fibrosis, and possible absence of pitting.